Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study.

Journal of Asthma and Allergy
Takanori NumataKazuyoshi Kuwano

Abstract

In Japan, biologic therapy was initiated for patients with severe asthma in 2009. In recent years, four biologics with different mechanisms of action have become available in the clinical setting. However, the efficacy of switching between biologics remains uncertain. To elucidate the efficacy of switching between biologics, 97 patients were enrolled who had received any biologic therapy for severe asthma at Jikei University Hospital, Tokyo, Japan, from July 2009 to December 2020. We retrospectively examined the patient characteristics, biomarkers, pulmonary function test results, selected biologics, and efficacy. Thirty-one males and 66 females received any biologics. The mean age was 53.3 years at the initiation of biologic therapy. Initially, 33, 41, 15 and eight patients received omalizumab, mepolizumab, benralizumab, and dupilumab, respectively. Among three representative indicators for biologics administration, the peripheral blood eosinophil count, serum IgE levels and fractional exhaled nitric oxide, 64% of the patients had two indicators, and 28% had three indicators. Thirty-four patients (35%) switched from the initial biologic to another, and the reasons for switching included persistent asthmatic symptoms (n=22), sc...Continue Reading

References

Apr 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN European Respiratory Society
Sep 22, 2009·The Journal of Allergy and Clinical Immunology·Michael SchatzPriti Jhingran
May 20, 2011·Allergology International : Official Journal of the Japanese Society of Allergology·Yuma FukutomiKazuo Akiyama
Mar 9, 2013·American Journal of Respiratory and Critical Care Medicine·Nicola A HananiaWilliam Busse
Sep 10, 2014·The New England Journal of Medicine·Hector G OrtegaUNKNOWN MENSA Investigators
Sep 10, 2014·The New England Journal of Medicine·Elisabeth H BelUNKNOWN SIRIUS Investigators
Dec 3, 2014·The Journal of Allergy and Clinical Immunology·Pieter-Paul W HekkingElisabeth H Bel
Dec 3, 2014·The Journal of Allergy and Clinical Immunology·Jennifer NamazyElizabeth B Andrews
Aug 25, 2016·American Journal of Respiratory and Critical Care Medicine·Loren C DenlingerUNKNOWN National Heart, Lung, and Blood Institute’s Severe Asthma Research Program-3 Investigators
Feb 16, 2017·Allergology International : Official Journal of the Japanese Society of Allergology·Masakazu IchinoseUNKNOWN Japanese Society of Allergology
May 23, 2017·The New England Journal of Medicine·Parameswaran NairUNKNOWN ZONDA Trial Investigators
Aug 15, 2017·The Journal of Allergy and Clinical Immunology. in Practice·Masako MatsusakaTomoko Betsuyaku
Feb 8, 2018·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Bradley E ChippsMitchell Goldman
Mar 14, 2018·ERJ Open Research·Eleftherios ZervasMina Gaga
Mar 17, 2018·The European Respiratory Journal·Marc HumbertUNKNOWN STELLAIR investigators
May 22, 2018·The New England Journal of Medicine·Mario CastroAriel Teper
May 22, 2018·The New England Journal of Medicine·Klaus F RabeAriel Teper
Sep 12, 2018·The Journal of Allergy and Clinical Immunology·William BusseNecdet B Gunsoy
Jun 21, 2019·Respiratory Medicine·Marc HumbertNamhee Kwon
Oct 14, 2019·BMC Pulmonary Medicine·Takanori NumataKazuyoshi Kuwano
Jan 26, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Masako ToYasuo To
Jun 3, 2020·Therapeutic Advances in Respiratory Disease·Giovanna Elisiana CarpagnanoMaria Pia Foschino Barbaro
Aug 14, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Yu Yu HanGang Wang
Sep 28, 2020·The Journal of Allergy and Clinical Immunology. in Practice·Carlo MümmlerKatrin Milger
Nov 19, 2020·Journal of Asthma and Allergy·Nora DrickHendrik Suhling

❮ Previous
Next ❯

Software Mentioned

StatView
GETE

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Zeitschrift für Rheumatologie
J R Kalden
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Chitra DinakarStephen A Tilles
Archivos de bronconeumología
Pere Casan Clarà, Cristina Martínez González
© 2021 Meta ULC. All rights reserved